Deven Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 860 in its research report dated July 25, 2025.

Buy Rossari Biotech; target of Rs 1034: KR Choksey

KR Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 1034 in its research report dated October 23, 2024.

Buy Rossari Biotech; target of Rs 1085: Anand Rathi

Anand Rathi is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 1085 in its research report dated October 22, 2024.

Hold Rossari Biotech; target of Rs 830: ICICI Securities

ICICI Securities recommended hold rating on Rossari Biotech with a target price of Rs 830 in its research report dated October 21, 2024.

Buy Rossari Biotech; target of Rs 931: KR Choksey

KR Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 931 in its research report dated July 24, 2024.

Buy Rossari Biotech; target of Rs 841: KR Choksey

KR Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 841 in its research report dated May 08, 2024.

Accumulate Rossari Biotech; target of Rs 843: KR Choksey

KR Choksey recommended accumulate rating on Rossari Biotech with a target price of Rs 843 in its research report dated October 27, 2023.

Buy Rossari Biotech; target of Rs 1015: YES Securities

YES Securities is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 1015 in its research report dated October 24 2023.

Reduce Rossari Biotech; target of Rs 720: ICICI Securities

ICICI Securities recommended reduce rating on Rossari Biotech with a target price of Rs 720 in its research report dated October 24, 2023.

Reduce Rossari Biotech; target of Rs 725: ICICI Securities

ICICI Securities recommended Reduce rating on Rossari Biotech with a target price of Rs 725 in its research report dated August 01, 2023.

Buy Rossari Biotech; target of Rs 982: KR Choksey

KR Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 982 in its research report dated August 01, 2023.

Buy Rossari Biotech; target of Rs 974: KR Choksey

KR Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 974 in its research report dated February 10, 2023.

Buy Rossari Biotech; target of Rs 1095: YES Securities

YES Securities is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 1095 in its research report dated February 07, 2023.

Buy Rossari Biotech; target of Rs 1252: KR Choksey

KR Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 1252 in its research report dated August 10, 2022.

Buy Rossari Biotech; target of Rs 1355: YES Securities

YES Securities is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 1355 in its research report date May 25, 2022.

Buy Rossari Biotech; target of Rs 1252: KR Choksey

KR Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 1252 in its research report dated May 24, 2022.

Buy Rossari Biotech; target of Rs 1456: KR Choksey

KR Choksey is bullish on Rossari Biotech has recommended buy rating on the stock with a target price of Rs 1456 in its research report dated March 28, 2022.

Rossari Biotech: Calibrated inorganic strategy opens up opportunities

Rossari’s M&A strategy is apparently focussed on encompassing complementary technology, talent, products and client base

Rossari Biotech: Market share gain in textile chemicals is comforting

In the longer term, what we like about Rossari Biotech is that it's led by technocrats with strong domain knowledge, which in turn has helped in superior execution of capex projects in the past and diversification into new end-markets

Rossari Biotech: Sharp recovery in legacy business adds to investment case

Rossari Biotech's growth is likely to be led by performance chemicals business in the medium term

Rossari Biotech: What next after a stellar post-listing run?

While Rossari Biotech has proven to be a strong beneficiary of the opportunity for chemical cleanliness solutions, its valuation is well ahead of fundamentals in our view